本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evommune

5.88
-0.1700-2.81%
盘后:5.80-0.0800-1.36%19:42 EDT
成交量:80.49万
成交额:475.79万
市值:2.13亿
市盈率:-2.25
高:6.05
开:6.05
低:5.85
收:6.05
52周最高:33.20
52周最低:5.85
股本:3,629.21万
流通股本:1,998.20万
量比:0.85
换手率:4.03%
股息:- -
股息率:- -
每股收益(TTM):-2.6090
每股收益(LYR):-11.2228
净资产收益率:-52.11%
总资产收益率:-31.99%
市净率:0.77
市盈率(LYR):-0.52

数据加载中...

公司资料

公司名字:
Evommune
交易所:
NYSE
成立时间:
2020
员工人数:
48
公司地址:
1891 Page Mill Road,Palo Alto,California,United States
邮编:
94304
传真:
- -
简介:
Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司,总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司,专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。

董事

名称
职位
Benjamin F. McGraw, III
Chairman of the Board and Director
Luis Peña
President,Chief Executive Officer and Director
Eugene A. Bauer
Chief Medical Officer and Director
Arthur Kirsch
Director
David E. Cohen
Director
Derek DiRocco
Director
Felice Verduyn van Weegen
Director
Francois Beaubien
Director
Robert Hopfner
Director
Yuexin Yu
Director

股东

名称
职位
Luis Peña
President,Chief Executive Officer and Director
Kyle Carver
Chief Financial Officer
Eugene A. Bauer
Chief Medical Officer and Director
Gregory S. Moss
Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer
Janice Drew
Executive Vice President,Operations
Jeegar Patel
Chief Scientific Officer